The Human Side of Clinical Trials: Why Fuzzy Mental Models Undermine Clinical Trial Execution

0:00-39:28

In Episode 3 of The Human Side of Clinical Trials, hosts Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., and Kelly Ritch, chief operating officer of ArcheMedX, Inc., speak with Jason Riis, PhD, CEO and chief behavioral scientist at Behavioralize, about why a well-written protocol doesn’t always translate into consistent execution, and how designing for the way people actually think and learn can reduce site burden and the need for costly unlearning.

Publisher

Applied Clinical Trials

Link

audioboom.com/posts/8964768

Published

October 15, 2026

Duration

39 min

Format

Podcast

Category

Issues · Science

Source

RSS feed

AC

Applied Clinical Trials

@appliedclinicaltrials

#humanside #fuzzymentalmodels #lifesciences

The Nile